z-logo
open-access-imgOpen Access
Site‐specific conjugation of bifunctional chelator BAT to mouse IgG 1 Fab 1 fragment
Author(s) -
LI Jun,
WANG Xuehao,
WANG Xiaoming,
CHEN Zhaolai
Publication year - 2006
Publication title -
acta pharmacologica sinica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.514
H-Index - 90
eISSN - 1745-7254
pISSN - 1671-4083
DOI - 10.1111/j.1745-7254.2006.00242.x
Subject(s) - conjugate , chemistry , bifunctional , cysteine , thiol , immunoglobulin fab fragments , chelation , maleimide , monoclonal antibody , stereochemistry , antibody , enzyme , biochemistry , peptide sequence , biology , catalysis , organic chemistry , immunology , mathematical analysis , mathematics , gene , complementarity determining region
Aim: To perform a site‐specific conjugation of Fab′ fragments of a mouse monoclonal antibody(MoAb) B43(of IgG 1 subtype) to a bifunctional chelator 6‐[ p ‐ (bromoacetamido) benzyl]‐1,4,8,11‐tetraazacyclotetradecane‐ N,N′,N″,N′″ ‐tetraacetic acid (BAT) via the thiol groups in the hinge distal to the antigenbinding site of the Fab′. Methods: B43 was cleaved using a simple 2‐step method. First, stable F(ab′) 2 was produced by pepsin treatment. Fab′ with free thiol in the hinge region was then obtained by cysteine reduction of F(ab′) 2 . Second, a sitespecific conjugation of Fab′ to thiol‐specific BAT was performed in a one‐step reaction. Results: The Fab′ fragment had approximately 1.8 free thiol groups per molecule after cysteine reduction. The conjugation efficiency and the chemical yield were approximately 1.28 moles chelator/Fab′ and 74% of the initial concentration of Fab′, respectively. The F(ab′) 2 , Fab′ and Fab′‐BAT all maintained reasonable antigen‐binding properties. 67 Cu labeling of the conjugate under standard conditions did not impair the immunoreactivity of Fab′‐BAT. Conclusion: This is a simple and efficient method for producing immunoreactive conjugates of Fab′‐ BAT, which can be used to make radiometal‐labeled conjugates for further diagnostic and therapeutic applications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here